Dimensional Fund Advisors LP Castle Biosciences Inc Transaction History

Dimensional Fund Advisors LP

  • $418 Billion
  • Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,378,005 shares of CSTL stock, worth $30.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,378,005
Previous 1,200,222 14.81%
Holding current value
$30.6 Million
Previous $24 Million 17.11%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$15.8 - $21.98 $2.81 Million - $3.91 Million
177,783 Added 14.81%
1,378,005 $28.1 Million
Q1 2025

May 13, 2025
BUY
$18.76 - $32.72 $3.77 Million - $6.57 Million
200,756 Added 20.09%
1,200,222 $24 Million
Q4 2024

Feb 13, 2025
BUY
$26.52 - $34.67 $3.57 Million - $4.67 Million
134,645 Added 15.57%
999,466 $26.6 Million
Q3 2024

Nov 07, 2024
BUY
$17.4 - $31.47 $955,033 - $1.73 Million
54,887 Added 6.78%
864,821 $24.7 Million
Q2 2024

Aug 09, 2024
BUY
$18.84 - $24.94 $1.14 Million - $1.51 Million
60,675 Added 8.1%
809,934 $17.6 Million
Q1 2024

May 10, 2024
BUY
$18.06 - $25.3 $1.54 Million - $2.16 Million
85,377 Added 12.86%
749,259 $16.6 Million
Q4 2023

Feb 07, 2024
BUY
$12.19 - $22.43 $1.32 Million - $2.43 Million
108,481 Added 19.53%
663,882 $14.3 Million
Q3 2023

Nov 09, 2023
BUY
$13.28 - $20.3 $874,063 - $1.34 Million
65,818 Added 13.44%
555,401 $9.38 Million
Q2 2023

Aug 09, 2023
BUY
$11.66 - $26.0 $69,155 - $154,206
5,931 Added 1.23%
489,583 $6.72 Million
Q1 2023

May 12, 2023
BUY
$19.47 - $28.49 $3.11 Million - $4.56 Million
159,966 Added 49.42%
483,652 $11 Million
Q4 2022

Feb 09, 2023
BUY
$18.08 - $30.0 $1.54 Million - $2.56 Million
85,198 Added 35.72%
323,686 $7.62 Million
Q3 2022

Nov 10, 2022
BUY
$22.51 - $34.32 $1.04 Million - $1.59 Million
46,410 Added 24.16%
238,488 $6.22 Million
Q2 2022

Aug 12, 2022
BUY
$16.0 - $45.99 $1.12 Million - $3.21 Million
69,700 Added 56.95%
192,078 $4.22 Million
Q1 2022

May 13, 2022
BUY
$33.17 - $46.98 $274,581 - $388,900
8,278 Added 7.26%
122,378 $5.49 Million
Q4 2021

Feb 09, 2022
BUY
$39.06 - $67.58 $2.34 Million - $4.04 Million
59,783 Added 110.06%
114,100 $4.89 Million
Q3 2021

Nov 12, 2021
BUY
$60.13 - $77.6 $3.27 Million - $4.21 Million
54,317 New
54,317 $3.61 Million
Q2 2021

Aug 12, 2021
SELL
$50.07 - $76.78 $7.16 Million - $11 Million
-142,988 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$58.92 - $97.33 $7.21 Million - $11.9 Million
122,306 Added 591.36%
142,988 $9.76 Million
Q4 2020

Feb 25, 2021
BUY
$43.6 - $73.05 $901,735 - $1.51 Million
20,682 New
20,682 $1.39 Million

Others Institutions Holding CSTL

# of Institutions
165
Shares Held
27.2M
Call Options Held
0
Put Options Held
0
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $585M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email